Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04459715
Title A Study of Debio 1143 in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Debiopharm International SA
Indications

laryngeal squamous cell carcinoma

oropharynx cancer

head and neck squamous cell carcinoma

hypopharynx cancer

Therapies

Cisplatin + Debio 1143

Cisplatin

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST